Immunogenicity Study of the Japanese Encephalitis Vaccine IC51

NCT00604708 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

867

Enrollment

INDUSTRY

Sponsor class

Conditions

Japanese Encephalitis

Interventions

BIOLOGICAL: IC51
BIOLOGICAL: JE-VAX

Sponsor

Valneva Austria GmbH